[Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D016316:Guanfacine; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D010648:Phenylacetates / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D006146:Guanidines; D010648:Phenylacetates; D016316:Guanfacine; D008750:Methyldopa
Ensayo "doble ciego" de un nuevo hipotensor de acción central, guanfacina, frente a alfa-metildopa.